All lobbying filings

HOLLAND & KNIGHT LLP

Lobbying for VIATRIS INC · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 18, 2026

Official filing document

Bills named in this filing 1

S 1302
Increasing Transparency in Generic Drug Applications Act

Lobbying activity 1

Pharmacy

S. 1302 - Increasing Transparency in Generic Drug Applications Act; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.